INVESTOR RELATIONS

FAQ

When was Ortho RTi founded?

The company was incorporated in February 2015 and its common shares have been listed in Canada since October 2017.

What is the company’s business focus?

Ortho RTi is an emerging Orthopaedic and Sports Medicine technology company dedicated to the development of novel therapeutic tissue repair technology to dramatically improve the success rate of sports medicine surgeries for soft tissue injuries.  Our proprietary biopolymer has been specifically designed to increase the healing rates of injuries to tendons, meniscus and cartilage. The polymer can be directly placed into the site of injury by a surgeon during a routine operative procedure without significantly extending the time of the surgery and without further intervention.

Where is Ortho RTi’s stock listed?

The company’s common shares are currently listed on the Canadian Stock Exchange (CSE) and trade under the symbol ORTH.

Who are Ortho RTi’s independent auditors?

MNP LLP
Chartered Professional Accountants

Who is Ortho RTi’s transfer agent and how does a registered shareholder contact the agent regarding account information?

The company’s transfer agent is Computershare Investor Services, Montreal

For Help With:

Please call Computershare’s National Customer Contact Centre:

Tel: 514-982-7888514-982-7888 (International)
Email: service@computershare.com

Mail:
Computershare Investor Services
650 de Maisonneuve west, 7th Floor
Montreal, QC  H3A 3T2

Who should I contact if I want to learn more about Ortho RTi

Corporate:

Brent Norton MD, MBA, ICD.D
Executive Chairman and CEO
514-782-0951514-782-0951
norton@orthorti.com

Investors & Media:

Stephen Kilmer
647-872-4849647-872-4849
stephen@kilmerlucas.com